Key result
Cardiac contractility modulation is a device-based therapy that enhances myocardial contractile strength in heart failure patients with normal QRS duration, requiring specific standardized implantation procedures.
Answers are grounded in this paper and cite their sources.
This technical guide outlines the patient selection, preoperative preparation, and surgical implantation techniques for delivering cardiac contractility modulation therapy in heart failure patients.
This article provides a technical description of common implant practice for delivery of cardiac contractility modulation (CCM) therapy to heart failure patients. As of September 2016, the authors of this article collectively have been involved with more than 400 system implantations in five medical centers, beginning with the advent of CCM therapy approximately 12 years ago. CCM therapy has been evaluated in a variety of studies, and was shown to be safe and effective and of benefit to patient quality of life and exercise capacity. As the use of CCM therapy continuously expands among medical centers in Europe, this article describes the technical and practical aspects of the implant procedure, and additional special technical cases based on our cumulative experience.
No takes yet. Share an insight, caveat, or question.
Kuschyk et al. (2017) conducted a review in Heart failure. Cardiac contractility modulation (CCM) was evaluated. Cardiac contractility modulation is a device-based therapy that enhances myocardial contractile strength in heart failure patients with normal QRS duration, requiring specific standardized implantation procedures.
Synapse has enriched 10 related papers. Consider them for comparative context: